Novartis' CAR-T therapy Kymriah racked up back-to-back approvals in acute lymphoblastic leukaemia and large B-cell lymphoma a few years ago, but hasn't added to its label since. Now, a bid to move ...

I only use a handful of them, but after testing apps on my phone for years, they've added up. Making my phone dumber provided an opportunity to clean house.